SCHEMBL3391675

SCHEMBL3391675

CCC(I)C(=NO)C(=O)c1ccc(Br)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.55
CES2 O00748 1/20 0.46
CES1 P23141 1/20 0.46
HDAC3 O15379 3/20 0.40
HDAC1 Q13547 3/20 0.40
HDAC2 Q92769 3/20 0.40
GSK3B P49841 2/20 0.40
OGG1 O15527 1/20 0.36
POLB P06746 1/20 0.36
CTDSP1 Q9GZU7 1/20 0.36
ALDH1A1 P00352 2/20 0.35
MAPT P10636 2/20 0.35
KMT2A Q03164 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
KDM4E B2RXH2 1/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
HDAC10 Q969S8 2/20 0.35
HDAC11 Q96DB2 2/20 0.35
HDAC8 Q9BY41 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29007609 0.76 GSK3B (0.47) HTTCES2CES1HDAC3HDAC1
SCHEMBL11372121 0.71 HTT (1.00) HTTCES2CES1HDAC3HDAC1
SCHEMBL11372119 0.71 HTT (1.00) HTTCES2CES1HDAC3HDAC1
SCHEMBL11982054 0.69 HTT (0.75) HTTCES2CES1HDAC3HDAC1
SCHEMBL4528980 0.69 HTT (0.75) HTTCES2CES1HDAC3HDAC1
SCHEMBL3391098 0.69 HTT (0.75) HTTCES2CES1HDAC3HDAC1
SCHEMBL10813395 0.69 CES2 (0.60) HTTCES2CES1HDAC3HDAC1
SCHEMBL11372320 0.69 CES2 (0.60) HTTCES2CES1HDAC3HDAC1
SCHEMBL10813399 0.69 CES2 (0.60) HTTCES2CES1HDAC3HDAC1
SCHEMBL557285 0.66 CES2 (1.00) HTTCES2CES1HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2242752-A1 IMIDAZOLYL BIPHENYL IMIDAZOLES AS HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2010-10-27 EP disclosed
WO-2009102325-A1 IMIDAZOLYL BIPHENYL IMIDAZOLES AS HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-08-20 WO disclosed